CHEMISTFROG writes on CTIX

http://seekingalpha.com/article/1118281-top-o...13-part-ii

Cellceutix Corporation ( CTIX.OB ) long time investors have enjoyed a solid stock run up in the last month, with shares reaching 52-week highs of $2.47 after the company traded below a dollar as recently as late November. The share price increase has come as a result of promising news on its lead drug candidate, Kevetrin™, a small molecule drug that reactivates tumor suppressor protein p53. Once reactivated (cancer cells have a way of inhibiting p53), p53 induces the expressions of p21 and PUMA (p53 up-regulated modulator of apoptosis). This reactivation inhibits cancer cell growth and causes tumor cell apoptosis (programmed cell death).

Some one I have followed for a long time.......now on board with us

go like his article and comment.....he has named CITX one of his bios for 2013